Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2655${count})

  • Therapeutic Pipeline Program, 2019
    Biomaterial-enhanced Cellular Brain Repair for Parkinson's Disease

    Study Rationale:
    One promising approach for the treatment of Parkinson’s is to replace the cells that have died in the disease through transplantation of healthy cells into the brain. However, this...

  • Epidemiological Parkinson's Risk Modifiers, 2019
    Study in French Population to Identify Therapies with Repurposing Potential for Parkinson’s Disease

    Study Rationale:
    There is an urgent need to identify effective, safe and inexpensive drugs for Parkinson’s disease, and over past years, there has been increasing interest on ways to repurpose...

  • Research Grant, 2019
    Pathogenesis of the Virome in Parkinson’s Disease

    Study Rationale:
    Numerous studies have implicated viruses as causal factors or potential triggers for Parkinson’s disease (PD). Our study will provide a comprehensive understanding of all the viral...

  • Astrocyte Biology in Parkinson's Disease, 2019
    Astrocyte Gene Expression in Parkinson’s Interrogated Using Single Cell Nuclear RNA Sequencing

    Study Rationale:
    Astrocytes are one of the major non-neuron cell types in the brain and control many neurological processes. They are likely to be changed in Parkinson’s disease (PD) and may...

  • Astrocyte Biology in Parkinson's Disease, 2019
    Characterization of Astrocytes in Aging and Lewy Body Pathology

    Study Rationale:
    Astrocytes are brain cells with crucial roles, including communication between nerve cells, clearance of unwanted material, and response to injury. It has been suggested that...

  • Research Grant, 2019
    Long-acting GM-CSF Fusion Protein (PDM608) for the Treatment of Parkinson’s Disease

    Study Rationale:
    Emerging evidence suggests that the modulating the peripheral immune system can be a powerful disease-modifying approach for the treatment of Parkinson's disease (PD). We have...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.